Citi Upgrades Sarepta Therapeutic (SRPT) to Neutral
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $127.39 +2.53%
Rating Summary:
30 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
30 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Citi upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Sell to Neutral.
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $33.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
- Goldman Sachs Upgrades Akzo Nobel NV (AKZA:NA) (AKZOY) to Neutral
- Leerink Partners Upgrades Tandem Diabetes Care (TNDM) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
